Rationale and Design of the First Double-Blind, Placebo-Controlled Trial with Allogeneic Adipose Tissue-Derived Stromal Cell Therapy in Patients with Ischemic Heart Failure: A Phase II Danish Multicentre Study

• Autori principali: Jens Kastrup (Autore), Morten Schou (Autore), Ida Gustafsson (Autore), Olav W. Nielsen (Autore), Rasmus Møgelvang (Autore), Klaus F. Kofoed (Autore), Charlotte Kragelund (Autore), Jens Dahlgaard Hove (Autore), Andreas Fabricius-Bjerre (Autore), Merete Heitman (Autore), Mandana Haack-Sørensen (Autore), Lisbeth Drozd Lund (Autore), Ellen Mønsted Johansen (Autore), Abbas Ali Qayyum (Autore), Anders Bruun Mathiasen (Autore), Annette Ekblond (Autore)
• Natura: Libro
• Pubblicazione: Hindawi Limited, 2017-01-01T00:00:00Z.
• Soggetti: article
• Accesso online: Connect to this object online.

Background. Ischemic heart failure (IHF) has a poor prognosis in spite of optimal therapy. We have established a new allogeneic Cardiology Stem Cell Centre adipose-derived stromal cell (CSCC_ASC) product from healthy donors. It is produced without animal products, in closed bioreactor systems and cr...